ArticleNucleic acids research2026
DAVID: a web server for functional annotation and functional enrichment analysis of gene lists (2025 update).
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Apigenin Alleviates Pyroptosis in Lung Adenocarcinoma Cells by Modulating TNF-α/NF-κB Signaling and AIM2 Inflammasome Activation.Thoracic cancer · 2026Article
- Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Observational
- Genome-Wide Identification and Characterization of theBiology · 2026Article
- Beyond Metabolism: Pyruvate Carboxylase Acts as a Sequence-Selective Small RNA Sensor Orchestrating Antiviral Responses.bioRxiv : the preprint server for biology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
DAVID is a widely used bioinformatics resource that provides functional annotation and functional enrichment analysis for gene and protein lists derived from high-throughput studies. It integrates a comprehensive gene-centered knowledgebase with a suite of web-accessible analytical tools. Since its initial release in 2003, DAVID developments have been published in 12 papers and cited >80 000 times. Here, we report updates made since the previous NAR Web Server Issue publication in 2022. This update introduces two new tools: DAVID Ortholog for cross-species functional analysis and DAVID Gene Search for identifier-agnostic gene exploration, modernizes the web interface, and implements a new backend architecture that decouples the frontend from the legacy Java processing engine. A new Servlet layer and REST APIs enable asynchronous processing and support integration of a Neo4j graph database for relationship-based queries. Major existing tools have been redesigned with modern, interactive interfaces, and multiformat result export. The pathway viewer has been redesigned with interactive drag-and-zoom navigation, animated user gene highlighting, and publication-quality downloads. Collectively, these updates enhance performance and usability, and the new backend architecture enables independent evolution of frontend and backend components while maintaining continuity with legacy analyses. DAVID remains freely available at https://davidbioinformatics.nih.gov without login.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.